Todays Top RNS's from Vox Markets: EnSilica, Helium One Global, Cizzle Biotechnology & More
EnSilica PLC - EnSilica Agrees a Multimillion Pound Contract
EnSilica plc has secured a multimillion-pound contract with an optical computing systems firm, boosting its design and manufacturing services. This development strengthens European-based supply chains and expands EnSilica's global reach, including a new design centre in Campinas, Brazil, to meet soaring demand for its services.
Helium One Global Ld - Jackson-4 Well Drilled to TD & Free Gas Confirmed
Helium One Global Ltd reports that the Jackson-4 well in the Galactica Project, Colorado, USA, was drilled to a total depth of 1,260ft, confirming free gas with no water identified. Natural gas flow and petrophysical analysis indicate high-quality, gas-saturated sands. The company plans further testing and well completion for potential production.
Cizzle Biotechnology - Update on Launch of CIZ1B Biomarker Assay
First COLA and CLIA Accredited Laboratory in USA Confirmed
Cizzle Biotechnology Holdings plc announces that its partner, Cizzle Bio Inc, has appointed iGenomeDX to launch the first commercial CIZ1B biomarker test for early-stage lung cancer detection in the USA. iGenomeDX, a COLA-accredited and CLIA-certified laboratory, will ensure high accuracy and reliability, marking a pivotal step toward commercial success.
Guardian Metal Rsrc. - Presidential Executive Order-US Mineral Production
Guardian Metal Resources plc (LON:GMET, OTCQX:GMTLF) highlights an Executive Order signed by President Donald Trump to boost U.S. mineral production. The order expedites permitting, prioritizes critical minerals like tungsten, and reduces foreign dependence. Guardian Metal, focused on Nevada projects, aligns with these goals to enhance domestic tungsten supply.
Seeing Machines Ltd - New Technology and Safety Leadership Appointments
Seeing Machines Limited appoints John Noble as Chief Technology Officer, enhancing technology strategy amidst increased demand for driver monitoring systems. Dr. Mike Lenné, a human factors authority, is named Chief Safety Officer to expand global safety partnerships. These leadership changes aim to drive innovation, safety, and revenue growth for the company.
ECR Minerals PLC - Exploration and Corporate Update
ECR Minerals is set to commence an antimony-focused drilling program at Bailieston in April 2025. The company plans additional drilling at the Lolworth Gold and Rare Earths project. With a strong financial position bolstered by asset sales, ECR aims to enhance portfolio value maximization while progressing its Blue Mountain Gold Project towards potential production.
Wood Group (John)PLC - Extension of PUSU deadline
Wood Group has extended the deadline for Sidara to announce its intention regarding a cash offer for the company, now set for April 17, 2025. Discussions continue with no guarantee of a firm offer. Shareholders need not take action at this stage, and further updates will follow.
Anglo Asian Mining - First ore mined from Gilar
Anglo Asian Mining PLC announces the first ore extracted from its new underground Gilar mine at the Gedabek site in Azerbaijan. The initial ore contains copper and gold, marking a significant milestone. The company is set to gradually increase production to achieve a monthly target of 50,000 to 60,000 tonnes of ore.
Hemogenyx Pharma Plc - First Patient Safety
Hemogenyx Pharmaceuticals plc has achieved a significant milestone with its HG-CT-1 CAR-T cell therapy for relapsed or refractory acute myeloid leukemia (R/R AML). The first patient treated showed no adverse effects, meeting initial safety assessments. Encouraging early efficacy signs propel the Phase I dose-escalation study, with ongoing patient monitoring and further trial updates anticipated.
Citius Resources PLC - Chairman's Statement
Harena Resources is moving towards the completion of feasibility studies at its Ampasindava ionic clay rare earths project in Madagascar. Much of the product is already earmarked for the US domestic market
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.